Karyopharm Therapeutics | DÍVIDA



Debt Alterar Data
AbbVie USD 67.14B 3.94B 2024-12
Abbott USD 13.24B 883M 2025-03
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Eli Lilly USD 38.52B 4.87B 2025-03
GlaxoSmithKline GBP 18.43B 1.45B 2025-03
Incyte USD 37.12M 840K 2025-03
J&J USD 52.25B 15.62B 2025-03
MacroGenics USD 0 0 2024-12
Merck USD 34.84B 2.27B 2025-03
Novartis USD 31.26B 828M 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Takeda JPY 4.52T 324.88B 2025-03
Tectonic Therapeutic USD 876K 115K 2024-12
TG Therapeutics USD 244.43M 271K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Xencor USD 154.38M 9.23M 2025-03



Karyopharm Therapeutics DÍVIDA - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2025.